Innovative urine test could improve pancreatic cancer survival rates

De­mo­c­rat Sens. Ed Markey of Mass­a­chu­setts and Joe Manchin of West Vir­ginia are call­ing on FDA Com­mis­sion­er Rob Califf not to per­mit the use of

Patient-reported outcome measures (PROMs) following knee and hip replacement procedures showed “a small improvement” over usual post-surgery care when patients were asked to submit them